NCT00834275View on ClinicalTrials.gov

Cefadroxil 500 mg Capsules Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Healthy
Interventions
DRUG

Cefadroxil 500 mg Capsules

1 x 500 mg

DRUG

DURICEF® capsules 500 mg

1 x 500 mg

Trial Locations (2)

77099

Bioassay Laboratory, Inc., Houston

M1L 4R6

Biovail Contract Research, Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00834275 - Cefadroxil 500 mg Capsules Under Fasting Conditions | Biotech Hunter | Biotech Hunter